{
    "organizations": [],
    "uuid": "67766d9f85197e69fa6ad14a6bfa52dde08afad3",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-shanghai-fosun-pharmaceutical-grou/brief-shanghai-fosun-pharmaceutical-group-units-receive-approval-for-drug-clinical-trials-idUSL4N1PJ1RR",
    "ord_in_thread": 0,
    "title": "BRIEF-Shanghai Fosun Pharmaceutical Group units receive approval for drug clinical trials",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 24 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd\n* Says two pharmaceutical units received drug clinical trials approval for capsule FCN-437c and crude drug, which will be mainly used for treatment of solid tumor\nSource text in Chinese: goo.gl/KA8dec\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-01-24T11:17:00.000+02:00",
    "crawled": "2018-01-24T15:37:53.020+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "shanghai",
        "fosun",
        "pharmaceutical",
        "group",
        "co",
        "ltd",
        "say",
        "two",
        "pharmaceutical",
        "unit",
        "received",
        "drug",
        "clinical",
        "trial",
        "approval",
        "capsule",
        "crude",
        "drug",
        "mainly",
        "used",
        "treatment",
        "solid",
        "tumor",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}